Trials / Completed
CompletedNCT05092438
QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001
An Observational, Retrospective, Clinical Performance Study Testing Residual Specimens of Cerebrospinal Fluid Obtained by Lumbar Puncture From Meningitis/Encephalitis Subjects Using the QIAstat-Dx® Meningitis/Encephalitis Panel
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 595 (actual)
- Sponsor
- QIAGEN Gaithersburg, Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study for performance evaluation of the QIAstat-Dx® Meningitis/Encephalitis Panel in comparison with other chosen comparator methods.
Detailed description
This multicenter study aims to evaluate the performance of QIAstat-Dx Meningitis/Encephalitis (ME) Panel with another validated comparator method.
Conditions
Timeline
- Start date
- 2021-10-08
- Primary completion
- 2021-12-02
- Completion
- 2021-12-02
- First posted
- 2021-10-25
- Last updated
- 2025-04-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05092438. Inclusion in this directory is not an endorsement.